National Oxygen Limited Files SEBI Compliance Certificate for Quarter Ended March 31, 2026
National Oxygen Limited filed its confirmation certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, through registrar Cameo Corporate Services Limited. The certificate confirms proper handling of securities dematerialisation and compliance with depositories regulations. Managing Director Rajesh Kumar Saraf submitted the filing to Bombay Stock Exchange on April 13, 2026.

*this image is generated using AI for illustrative purposes only.
National Oxygen Limited has filed its quarterly compliance certificate with the Bombay Stock Exchange, confirming adherence to SEBI regulations for the quarter ended March 31, 2026. The submission demonstrates the company's commitment to regulatory compliance in securities handling and dematerialisation processes.
Regulatory Compliance Filing
The company submitted the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 13, 2026. Managing Director Rajesh Kumar Saraf signed the filing, which was addressed to the Department of Corporate Services at the Bombay Stock Exchange.
| Filing Details: | Information |
|---|---|
| Regulation: | SEBI Regulation 74(5) |
| Quarter Ended: | March 31, 2026 |
| Filing Date: | April 13, 2026 |
| Signatory: | Rajesh Kumar Saraf, Managing Director |
| DIN: | 00007353 |
Certificate Confirmation
Cameo Corporate Services Limited, serving as the company's registrar and share transfer agent, issued the compliance certificate. The certificate confirms that securities received from depository participants for dematerialisation during the quarter were properly processed and confirmed to the depositories within stipulated timeframes.
Key Compliance Confirmations
The certificate validates several critical compliance aspects:
- Securities received for dematerialisation were confirmed (accepted/rejected) to depositories
- Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
- Security certificates received for dematerialisation were mutilated and cancelled after due verification
- Depository names were substituted in the register of members as registered owners within stipulated time limits
Company Operations
National Oxygen Limited operates as an ISO 9001:2015 certified manufacturer of industrial and medical gases. The company produces liquid and gaseous oxygen, nitrogen, nitrous oxide, medical oxygen, and dissolved acetylene gas through its three manufacturing facilities located in Puducherry, Erode, and Pudukkottai districts.
The quarterly filing reflects the company's ongoing commitment to maintaining regulatory compliance while continuing its operations in the industrial gases sector. The proper handling of securities dematerialisation ensures investor confidence and adherence to market regulations.
Historical Stock Returns for National Oxygen
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.30% | +4.62% | +11.38% | -37.61% | -34.90% | +23.30% |
How might National Oxygen's expansion plans be affected by recent regulatory changes in the industrial gases sector?
What impact could rising demand for medical oxygen post-pandemic have on the company's production capacity and revenue growth?
Will National Oxygen consider establishing additional manufacturing facilities beyond its current three locations to capture market opportunities?




























